Comparison

APL-1092 European Partner

Item no. HY-169324
Manufacturer MedChem Express
CASRN 2921735-91-1
Amount 1 ea
Category
Type Crosslinkers
Specific against other
Citations [1]Watanabe T, et al. Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates. J Med Chem. 2024 Oct 24;67(20):18124-18138.
Smiles O=C(C=CC1=O)N1CCCCCNC(C(C2=CC=C(C=C2)NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@@H](NC(C)=O)CCC(O)=O)=O)=O)=O)=O)OC(N[C@@H]3C4=C5C(C(N6C5)=CC([C@](O)(C(OC7)=O)CC)=C7C6=O)=NC8=CC(F)=C(C)C(CC3)=C84)=O)=O
ECLASS 10.1 32170205
ECLASS 11.0 32170205
UNSPSC 41105316
Alias Mal-Exo-EEVC-Exatecan
Shipping Condition Room temperature
Available
Manufacturer - Type
ADC Related
Manufacturer - Applications
Cancer-programmed cell death
Shipping Temperature
Room temperature
Molecular Weight
1349.37
Product Description
APL-1092 (Mal-Exo-EEVC-Exatecan) is a drug-linker conjugate for ADC, which contains Exatecan (HY-13631) (ADC payload) and a linker[1].
Manufacturer - Research Area
Cancer
Manufacturer - Pathway
Antibody-drug Conjugate/ADC Related
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close